Citius Pharmaceuticals 주식 (NASDAQ: CTXR)

Citius Pharmaceuticals (NASDAQ:CTXR) 주식

CITIUS PHARMACEUTICALS INC

Citius Pharma

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Things To Keep In Mind While Gifting Stocks

News

Pre-Market Outlook

Markets

Trading Ideas

$LUNA

CCTG

CTXR

LUNA

월요일(30일) 아침 미국 주식 선물이 하락한 가운데, 오늘 투자자들의 관심을 끌 수 있는 종목은 다음과 같다. 셀 사이, CCSC 테크놀로지, 루나 이노베이션스, 시티우스 파마슈티컬스 및 지니어스 그룹

월요일 주목해야 할 주식: 셀 사이, CCSC 테크놀로지, 루나 이노베이션스, 시티우스 및 지니어스 그룹

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals Inc

President Donald Trump is facing a lawsuit over the 20% tariffs imposed on Chinese goods. This marks the first known legal challenge against these tariffs.
What Happened: The lawsuit, filed on Thursday, challenges Trump&#8217;s use of the International Emergency Economic Powers Act of 1977, <a href="https://thehill.com/homenews/5231388-trump-sued-over-china-tariffs/">reported</a> The Hill. It argues that while the IEEPA allows for asset freezes and economic sanctions, it does not authorize tariffs. The lawsuit claims, "Congress passed the IEEPA to counter external emergencies, not to grant presidents a blank check to write domestic economic policy."
The New Civil Liberties Alliance filed the lawsuit on behalf of Simplified, a Florida-based small business that sells planners and sources products from China. The suit, filed in federal court in Pensacola, Florida, seeks a judicial declaration that the tariffs are unlawful and requests their enforcement be halted.
Initially, Trump imposed a 10% tariff on Chinese goods via an executive order on February 1, which was doubled to 20% on March 3. This was followed by a broader announcement introducing a 10% general tariff on U.S. imports and higher rates for several countries, including an additional 34% tariff on China, culminating in a total of 54%.
See Also: <a href="https://benzinga.com/news/25/03/44575557/mark-cuban-says-if-they-replaced-elon-musk-with-him-hes-still-try-to-make-government-smaller-by-cutting-a-lo" target="_blank" rel="noreferrer noopener">Mark Cuban Says, If They Replaced Elon Musk With Him, He&#8217;s Still Try to Make Government Smaller By &#8216;Cutting A Lot Of People&#8217;</a>
Why It Matters: The tariffs have sparked <a href="https://in.benzinga.com/economics/macro-economic-events/25/04/44626421/trumps-reign-of-tariffs-unleashes-d-day-on-wall-street-analyst-warns-of-stagflation-risk">significant concern</a> among economists and market analysts. According to Ed Yardeni, president of Yardeni Research, the sweeping tariffs could lead the U.S. economy toward stagflation, a scenario characterized by stagnant growth and rising inflation. 
This sentiment was echoed by Larry Summers, former Treasury Secretary, who compared the tariffs&#8217; impact to an &#8220;oil crisis-like shock,&#8221; <a href="https://www.benzinga.com/markets/25/04/44623179/larry-summers-warns-trumps-tariffs-will-deliver-oil-crisis-like-shock-slash-30-trillion-from-economy-as-markets-plunge">potentially slashing $30 trillion</a> from the economy.
Additionally, the tariffs have heightened the risk of retaliatory measures from major trading partners. Speculators have already begun pricing in the likelihood of increased retaliatory tariffs, as noted by <a href="https://in.benzinga.com/top-stories/25/04/44627817/retaliation-odds-spike-after-trumps-heavy-tariffs-sending-country-etfs-tumbling">recent trading activity</a> on the CFTC-regulated prediction platform Kalshi.
U.S. stocks tumbled after the tariffs were announced, with the Dow Jones Industrial Average dropping 4% to close at 40,545.93 on Thursday. The S&amp;P 500 slid 5% to 5,396.52, while the tech-heavy Nasdaq suffered the steepest losses, plunging nearly 6% to 16,550.61.
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Too</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

General

Trump Gets Sued Over China Tariffs: Congress Did Not Grant Presidents 'Blank Check To Write Domestic Policy'

Ever feel like your to-do list has a mind of its own? Melinda French Gates has a solution, and it&#8217;s surprisingly simple: start saying no. It turns out that Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, BRK.B)) CEO <a href="https://www.benzinga.com/startups/25/02/43466203/warren-buffetts-127-billion-stock-sell-off-sends-wall-street-a-stark-warning-for-2025-below-average-returns-ahead">Warren Buffett</a> gave her this advice years ago, and it has been a game-changer ever since.
<h2 class="wp-block-heading">The Billionaire Rule for Getting More Done</h2>
French Gates, co-chair of the Bill &amp; Melinda Gates Foundation, recently shared this golden nugget of wisdom on a recent LinkedIn&#8217;s podcast, &#8220;<a href="https://podcasts.apple.com/us/podcast/melinda-french-gates-on-owning-your-power-and-leading/id1453893304?i=1000699461420">Hello Monday</a>.&#8221;&nbsp;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>
&nbsp;&#8220;When we created our foundation, Buffett told us, &#8216;Know where your bullseye is. If you keep your eye on your target, you&#8217;ll focus on what matters most.&#8217; I&#8217;m grateful to Warren for his friendship, wisdom, and support,&#8221; she said. In other words, stop trying to do everything—zero in on what truly matters.
This isn&#8217;t just self-help talk. A marketing leader, certified executive coach, and founder of Cove &amp; Compass,<a href="https://www.lauranguyen.co/blog/why-establishing-boundaries-is-essential-for-protecting-your-time-in-2025"> Laura Nguyen</a> emphasizes setting clear boundaries, especially in the digital world where constant availability consumes most of our time. That&#8217;s the work-life balance jackpot.&nbsp;
Buffett has lived by this principle for decades. Back in 2014, he shared his famous &#8220;two-list&#8221; strategy with his pilot, Mike Flint. The trick? Write down 25 career goals, pick the five most important, and ignore the rest completely. The idea is that half-committing to everything leaves you fully committed to nothing.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Not everyone thinks saying no is the magic solution. TV producer Shonda Rhimes—the mastermind behind "Grey&#8217;s Anatomy"—went viral for her &#8220;Year of Yes&#8221; philosophy. Ten years later, she offers a candid<a href="https://www.youtube.com/watch?v=CGCZadtBSR4"> review</a> of her bold decision.&nbsp;
&#8220;Ten years ago, I had this epiphany that I would spend a year saying yes to everything that scared me. The very act of doing the thing that scared me undid the fear. It&#8217;s amazing how powerful one word can be. &#8216;Yes&#8217; changed my life; &#8216;Yes&#8217; changed me.&#8221;&nbsp;
On the flip side, productivity expert Tim Ferriss has built an entire brand on the idea of selective no&#8217;s. He frequently talks about the 80/20 rule, which suggests that 80% of success comes from just 20% of efforts. If that&#8217;s true, cutting out the distractions could be the key to leveling up. One way of cutting such distractions is by learning to say no.&nbsp;
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
<a href="https://tim.blog/2025/01/13/the-no-book/">An excerpt introducing his book</a>, "The No Book" published on his blog, says, &#8220;The goal of life is to make good decisions. And decisions are the simplest thing in the world. They consist of a single choice between &#8221; yes &#8221; &#8221; or &#8221; no.&#8221; Tim recommends saying no to help set clear boundaries and eliminate distractions.
Author James Clear summed it up perfectly in a <a href="https://x.com/jamesclear/status/956172562756722690">post on X:</a> When you say no, you only say no to one option. When you say &#8216;yes,&#8217; you say &#8216;no&#8217; to every other option. &#8216;No&#8217; is a decision. &#8216;Yes&#8217; is a responsibility. Be careful what (and to whom) you say &#8216;yes&#8217;. It will shape your day, career, family, and life.&#8221;
Historically, some of the world&#8217;s most successful people have followed Buffett&#8217;s strategy. According to <a href="https://www.entrepreneur.com/business-news/how-jony-ive-helped-saved-apple-from-bankruptcy-in-the-1990s/487599">Entrepreneur</a>, Steve Jobs tasked the Apple's vice president of industrial design at the time, Jony Ive, with creating the iMac, a user-friendly and visually appealing computer, upon returning to the company in 1997.&nbsp;
This strategic focus on simplifying the product lineup and emphasizing design innovation was instrumental in revitalizing <a href="https://www.benzinga.com/news/25/03/44109824/apples-500b-u-s-investment-analyst-calls-it-completely-unrealistic-questions-where-the-money-will-come-from">Apple </a>and steering it away from bankruptcy
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

Personal Finance

Melinda French Gates Says This Lesson From Warren Buffet Was Life Changing

Most people think building a nest egg is the hard part. But according to billionaire BlackRock CEO Larry Fink, the real challenge is what comes after.
"When we took the average of the responses, it was just over $2 million—$2,089,000, to be exact," Fink wrote in his <a href="https://www.blackrock.com/corporate/investor-relations/larry-fink-annual-chairmans-letter">2025 annual letter to investors</a> earlier this week. "That's a lot. More than I was expecting. And almost no one is close."
The number came from a January survey BlackRock conducted, asking Americans how much they thought <a href="https://www.benzinga.com/personal-finance/24/08/40465160/think-youre-saving-enough-heres-what-the-top-10-have-saved-for-retirement">they'd need to retire comfortably</a>. The average response? Over $2 million.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>
Now pause for a second. Here's what people actually have. A 2024 <a href="https://news.prudential.com/latest-news/prudential-news/prudential-news-details/2024/2024-Pulse-of-the-American-Retiree-Survey/default.aspx">survey from Prudential</a> found that Gen Xers have a median of just $47,950 saved.&nbsp;
And it gets worse. A 2023 study from the <a href="https://www.nirsonline.org/2023/07/new-report-finds-alarming-retirement-outlook-for-generation-x-3/">National Institute on Retirement Security</a> found the typical Gen X household had just $40,000 in retirement savings. While the average balance reported in a <a href="https://www.bankrate.com/investing/survey-young-americans-optimistic-retirement/">Bankrate survey</a> is $153,300, that figure is often skewed by higher earners with large accounts.&nbsp;
So when Fink says, "That's a lot… and almost no one is close," he's not exaggerating. <a href="https://www.benzinga.com/personal-finance/24/08/40561911/gen-x-is-so-unprepared-for-retirement-theyre-being-called-silver-squatters-because-1-in-5-are-co">Even older Gen-Xers</a>, now just a few years from retirement, are falling short. As Fink noted, 62% have saved less than $150,000.
"We're going to need better ways to boost portfolios," he said. One option? Private assets—like real estate and infrastructure—which Fink says have long helped pension funds outperform traditional 401(k)s. On average, pensions earn about 0.5% more per year than 401(k)s, thanks in part to those asset classes.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
"Half a percent doesn't sound huge," Fink explained. "But over 40 years, it adds up. An extra 0.5% in annual returns results in 14.5% more money in your 401(k)." That's the difference between scraping by and retiring on your own terms—or as Fink put it, "nine extra years hanging out with your grandkids."
But while pensions have embraced private assets for decades, most 401(k)s still haven't.&nbsp;
Fink blames unfamiliarity, rigid plan structures, and a lingering perception that these investments are too opaque or illiquid.
"When you invest in private assets—like a bridge, for example—you can't withdraw your money whenever you want," he said. "It's a bridge, after all—not a stock."
Fink believes that's starting to change. BlackRock has been working to bring more transparency and liquidity to these markets, and his firm recently introduced LifePath Paycheck—a product that converts 401(k) savings into reliable monthly income.
See Also: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
In just one year, it's been adopted by six plan sponsors representing 200,000 retirement savers. But Fink isn't ready to declare victory.&nbsp;
"The problem will only get harder and nastier," he warned, "as the oldest Gen-Xers start to retire."
That echoes economist Bill Sharpe, who famously called the drawdown phase of retirement—the part where you have to figure out how to make your money last—as "the nastiest, hardest problem in finance."
People with pensions don't worry about this. They get a steady monthly check. But 401(k) savers? They're handed a lump sum and told to make it last—without knowing how long they'll live or what unexpected costs might pop up.
Even people who've saved well often play it too safe, afraid to spend. They delay joy. They downsize dreams. And now, with $2 million as the <a href="https://www.benzinga.com/money/smartasset">new retirement benchmark</a>, the fear is only growing.
Read Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>

'That's a Lot' — Billionaire BlackRock CEO Larry Fink Says People Need $2.08 Million to Retire Comfortably, But 'Almost No One Is Close'

Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has outperformed the market over the past 10 years by 15.12% on an annualized basis producing an average annual return of 25.06%. Currently, Amazon.com has a market capitalization of $1.88 trillion. 
Buying $1000 In AMZN: If an investor had bought $1000 of AMZN stock 10 years ago, it would be worth $9,530.19 today based on a price of $178.40 for AMZN at the time of writing.
<h3>Amazon.com's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743720310_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Anyone following <a href="https://www.benzinga.com/topic/mlb">Major League Baseball</a> in the 2025 season has heard about torpedo bats, a new trend of bats that have seen impressive results for those using them.
A deep dive into legal bats shows soaring demand and a public company that gives investors exposure to the latest hitting trend.
What Happened: The New York Yankees lost the<a href="https://www.benzinga.com/general/sports-betting/24/10/41521768/world-series-yankees-dodgers-showdown-could-boost-fox-betting-odds-how-to-watch-matchup-of"> 2024 World Series,</a> but if early results for the 2025 season are any indication, the team may be back with a vengeance.
The Yankees are currently 3-2 on the season and the team&#8217;s run differential of +19 ranks third best in the league behind the undefeated Los Angeles Dodgers (+22, 8-0) and San Diego Padres (+25, 7-0) which have played more games than them.
Through the first four games of the season, the Yankees had 18 home runs, breaking an MLB record for the first four games of any season. The team also had nine players hit home runs in the stretch and three players hit at least three home runs in the stretch, MLB firsts, as reported by <a href="https://www.cnn.com/2025/04/02/sport/yankees-home-run-record-torpedo-bats-spt/index.html">CNN</a>.
Helping the Yankees make history could be torpedo bats, a newer customized bat that is shaped like a torpedo and allocates extra wood to each hitter's "sweet spot."
The bats are legal as they fall within length and wood requirements and are made by an MLB-approved manufacturer.
Among the Yankees players using the bats are Anthony Volpe, Jazz Chisholm Jr., Cody Bellinger and Paul Goldschmidt.
"I don't know the science of it… I think I still hit the ball the same, like, exit velocity as I always did. I just feel like it gives you a feeling of — just feeling like you have more to work with," Chisholm Jr. said, as reported by <a href="https://www.cnn.com/2025/03/31/sport/torpedo-bats-mlb-yankees-explained-spt/index.html">CNN</a>.
The bats were developed by former MIT physicist Aaron "Lenny" Leanhardt, who spent time with the Yankees organization and is now a staff member for the Miami Marlins.
Read Also: <a href="https://www.benzinga.com/general/sports/24/10/41283005/warren-buffett-home-run-billionaires-baseball-bet-could-rise-in-value-with-minnesota-twins-sale">Warren Buffett Home Run? Billionaire&#8217;s Baseball Bet Could Rise In Value With Minnesota Twins Sale</a>
The Winning Company? While the big question will be if torpedo bats continue to see demand from MLB players and other baseball players, one company is already seeing increasing sales.
Victus president Jared Smith told <a href="https://www.cllct.com/sports-collectibles/memorabilia/swing-like-the-pros-torpedo-bats-now-available-for-anyone-to-order">cllct </a>that he has not seen demand like the torpedo bat in his 15 years in the industry.
"Of course, we are going to lean into it," Smith told cllct.
Smith said the Yankees and Baltimore Orioles are among the teams that have tested torpedo bats in the company's bat lab.
Smith said the question is how long the demand will last.
"It will definitely be here for good now. I'm not sure if it will take over the league or it will just be a fad."
Victus is <a href="https://ir.compassdiversified.com/news-releases/news-release-details/compass-diversified-completes-sale-marucci-sports">owned </a>by Fox Factory Holding Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXF#NASDAQ">FOXF</a>), a company known better for its bikes.
"The Torpedo has definitely achieved cool status," Smith added.
Fox Factory's business lines are predominantly bicycles, on-road and off-road vehicles, side-by-side vehicles, all-terrain vehicles and vehicle products. The company acquired Marucci and Victus, two baseball equipment makers, in 2023. The companies are the makers of the official bats for Major League Baseball. 
&#8220;Torpedo Shape. Victus Built. Get your hands on the most talked-about bat in the game,&#8221; Victus&#8217; <a href="https://victussports.com/">website </a>reads. 
Fox Factory's fourth-quarter financial <a href="https://investor.ridefox.com/press-releases/news-details/2025/Fox-Factory-Holding-Corp.-Reports-Fourth-Quarter-Fiscal-2024-Financial-Results/default.aspx">results </a>saw the company's Specialty Sports Group post a 33.3% year-over-year increase in net sales helped by the acquisition.
The next quarterly results from Fox Factory could show if there was an immediate impact for this business segment thanks to torpedo bats. The company commentary could also highlight if it is boosting guidance for the sports segment.
Why It's Important: Sports leagues evolve and new technology often makes players and teams better, which sometimes can break records and also create a more enjoyable experience for fans.
Betting on players to hit home runs has become a top bet for sportsbooks for the MLB season. Both DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) and Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) -owned FanDuel are leaning into the torpedo bats. Each sportsbook has sections featuring players who have used torpedo bats during the season.
On DraftKings, bettors can easily place wagers on the players using torpedo bats to hit a home run, get an RBI or hit a double. It&#8217;s not just Yankees players who are using the torpedo bats either.
Some players and baseball fans are skeptical of the torpedo bats and while legal, question the integrity of those using them.
"It's about fairness and equality," Barstool Sports founder Dave Portnoy <a href="https://www.foxbusiness.com/media/dave-portnoy-slams-yankees-torpedo-bats-warns-infiltrating-sacred-game-baseball">said </a>in a recent interview.
Portnoy said his hatred of torpedo bats is not about his dislike for the Yankees, but instead for the integrity of the game.
As long as MLB players keep hitting home runs with torpedo bats, the newer hitting tool will likely be a trending topic in baseball. 
FOXF Price Action: Fox Factory stock closed Thursday down 15.92% at $20.91 versus a 52-week trading range of $20.78 to $54.86, hitting new yearly lows on Thursday. The stock is down 25.6% year-to-date and over 50% over the past year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/sports/24/12/42395738/juan-sotos-765-million-mets-contract-could-be-bad-news-for-warren-buffett">Juan Soto&#8217;s $765 Million Mets Contract Could Be Bad News For Warren Buffett</a></li>
</ul>
Photo: Elliott Cowand Jr, Shutterstock.com

Sports

DKNG

FLUT

FOXF

Torpedo Bats Take Over MLB, Sportsbooks: Public Company Sees Soaring Demand For Home Run Hitting Baseball Bat

<ul>
<li>BlackRock CEO Larry Fink has warned that Bitcoin could usurp the U.S. dollar.</li>
<li>Fink has sounded the alarm on U.S. debt.</li>
<li>Ironically, some also see Bitcoin as the solution to the U.S.&#8217;s problems.</li>
</ul>
BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) CEO Larry Fink has joined the chorus of voices warning that the U.S. dollar&#8217;s reserve currency status is at risk. Unlike most, however, he has gone one step further to suggest a likely replacement: Bitcoin.
<h2 class="wp-block-heading">Why BlackRock&#8217;s Larry Fink Thinks Bitcoin Might Usurp The Dollar</h2>
Fink <a href="https://www.blackrock.com/corporate/literature/presentation/larry-fink-annual-chairmans-letter.pdf">warned</a> in his annual letter on Monday to investors that Bitcoin could replace the U.S. dollar as the world&#8217;s reserve currency.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a></li>
</ul>
While much of the recent concern around the dollar&#8217;s reserve status has been triggered by President <a href="https://www.benzinga.com/markets/equities/25/03/44554008/wall-street-on-edge-futures-slide-ahead-of-trumps-liberation-day-tariff-shock">Donald Trump&#8217;s tariff policy</a>, Fink pointed to the U.S.&#8217;s ballooning national debt as the primary concern.
At the time of writing, this debt stands at over $36 trillion and, according to Fink, is growing at an unsustainable rate.
Specifically, Fink lamented that the national debt has grown three times the U.S. GDP since 1989, with interest payments at $952 billion set to surpass defense spending this year. He also argued that government spending and debt servicing were on pace to surpass all government revenue by 2030, creating a permanent deficit.
&#8220;If the U.S. doesn&#8217;t get its debt under control, if deficits keep ballooning, America risks losing that position to digital assets like Bitcoin,&#8221; he wrote.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Nonetheless, Fink stressed that his warning wasn&#8217;t meant to be missive against digital assets.&nbsp;
&#8220;I&#8217;m obviously not anti-digital assets (far from it; see the next section). But two things can be true at the same time: Decentralized finance is an extraordinary innovation. It makes markets faster, cheaper, and more transparent. Yet that same innovation could undermine America&#8217;s economic advantage if investors begin seeing Bitcoin as a safer bet than the dollar,&#8221; he wrote.
Indeed, Fink has become <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43150952/blackrock-ceo-larry-fink-says-bitcoin-could-rise-to-700000-on-fiat-fears-if-youre-frightened-of-the-debasement">a vocal proponent of Bitcoin</a> over the past year, especially since BlackRock launched a spot Bitcoin exchange-traded fund. This fund is the largest Bitcoin ETF in the world, with $48 billion in assets under management at the time of writing.
BlackRock has also dived headfirst into tokenization, with <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44473477/blackrock-brings-tokenized-money-market-fund-buidl-to-solana">its tokenized money market fund BUIDL</a> spread across seven blockchains and boasting over $1.7 billion in assets under management. In Fink&#8217;s latest annual letter to investors, he tipped tokenization to do for finance what email did for communication.
Fink&#8217;s recent statements come as, perhaps ironically, some have tipped Bitcoin as the solution to the U.S.&#8217;s rising debt problem.
See Also: <a href="https://www.benzinga.com/money/startengine-own">The $1.3 billion startup investment boom: How this company's explosive growth is opening doors for everyday investors with a new $500 minimum</a>
<h2 class="wp-block-heading">Is A Bitcoin Strategic Reserve The Answer?</h2>
Strong Bitcoin, supporters such as Sen. Cynthia Lummis (R-WY) and Strategy. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) Chair <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44274267/michael-saylors-bitcoin-superpower-strategy-could-it-generate-106-trillion-for-the-us">Michael Saylor have argued</a>, that the U.S. can tackle its debt problem by accumulating the leading cryptocurrency.
The argument is based on the belief that Bitcoin will eventually soar to over seven figures, and with a large enough stash, the U.S. can leverage it to neutralize debt and attract capital.
It is an idea that Trump also flirted with on the campaign trail, <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40983160/donald-trump-sees-good-future-for-crypto-suggests-it-could-help-pay-off-35-trillion-nation">asserting in September</a> that perhaps the U.S. could pay off its debt in crypto.
While economists debate whether this is feasible, Trump already appears to have taken the first step in line with this Bitcoin strategy <a href="https://www.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">by establishing a U.S. reserve</a> through an executive order.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

MSTR

BlackRock's Larry Fink Warns Dollar Risks Losing Reserve Currency Status To Bitcoin

The New York Mets have started the 2025 <a href="https://www.benzinga.com/topic/major-league-baseball">Major League Baseball </a>season with a 3-3 record. Investors could soon be rooting for the team to hit the 100-win milestone thanks to a new multimillion-dollar sponsorship.
What Happened: Trading platform moomoo <a href="https://www.globenewswire.com/news-release/2025/04/03/3055569/0/en/Moomoo-and-the-NY-Mets-Announce-Strategic-Partnership-to-Elevate-Fans-Experience-to-the-Next-Level.html">announced </a>a new strategic partnership with the Mets on Thursday that could award one lucky customer $1 million.
The trading platform, which is owned by Futu Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), will have permanent and rotational signage at CitiField during Mets games, including on the moomoo bullpen.
To celebrate the partnership, moomoo is offering cash prizes for customers based on the number of wins the Mets reach in the 2025 season.
Moomoo will pay out $1 million to one investor if the Mets win 100 games during the season. That potential grand prize drawing will take place on Sept. 28, 2025. Moomoo will also pay out prizes of $10,000 for 25 wins, $20,000 for 50 wins and $30,000 for 75 wins if the Mets reach those milestones.
The <a href="https://invest.us.moomoo.com/moomoomillion">contest </a>is open to people living in New York, New Jersey or Connecticut who open a moomoo account and place a deposit or mail a postcard to moomoo.
"We are very excited to partner with New York Mets, not only because I am a baseball fan, but also because we are committed to elevating the fan experience through various interactive games and promotions," moomoo's U.S. CEO Neil McDonald said.
The tagline "from bullpen to bull-market, moomoo, your powerful trading platform" will be used for the sponsorship and promotion.
"As more fans become financially savvy and explore online trading, this is a great opportunity to utilize a new, user-friendly platform while also receiving select benefits for upcoming Mets games," Mets President of Business Operations M. Scott Havens said.
Read Also:<a href="https://www.benzinga.com/general/sports/24/12/42395738/juan-sotos-765-million-mets-contract-could-be-bad-news-for-warren-buffett"> Juan Soto&#8217;s $765 Million Mets Contract Could Be Bad News For Warren Buffett</a>
Why it's Important: Moomoo's global presence includes 25 million users and the new sponsorship could be a way to add additional users in the growing competitive trading platform sector.
In the fourth quarter, Futu <a href="https://ir.futuholdings.com/static-files/135c4132-48f1-408c-80b5-f178dda1b712">reported </a>paying clients up 41% year-over-year, registered clients up 28.7% year-over-year and total number of users up 16.2% year-over-year.
Trading platform Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) recently offered a $1 million prize in Bitcoin to users who participated in the company's 12-question multiple choice trivia game. The contest was played by over 300,000 people and was a way for Robinhood to try and promote its Gold subscription service.
As for the Mets chances of 100 wins, sportsbooks predict the team to be one of the top MLB teams in the 2025 season.
At DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), the Mets have the fifth-best odds of winning the World Series at +1,400. At FanDuel, which is owned by Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>), the over/under on the Mets wins for the season currently sits at 91.5, suggesting a likely total of 92 wins.
Last season, the Mets went 89-73 and made the playoffs. There were seven teams with 90 wins last season, but none eclipsed the 100-win plateau with the Los Angeles Dodgers closest at 98 wins.
The Mets have won 100 or more games several times in their history, including going 101-61 in 2022 and winning 100 or more in 1988, 1986 and 1969.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/06/39482302/steve-cohen-bets-on-las-vegas-new-york-mets-owner-takes-5-5-stake-in-sphere-could-more-spor">Steve Cohen Bets On Las Vegas: New York Mets Owner Takes 5.5% Stake In Sphere, Could More Sports Events Be On The Horizon?</a></li>
</ul>
Photo: Nyker, Shutterstock

Entertainment

FUTU

HOOD

Moomoo To Give Away $1 Million If New York Mets Win 100 Games: How You Can Win The Grand Prize

Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has outperformed the market over the past 20 years by 6.56% on an annualized basis producing an average annual return of 14.4%. Currently, Microsoft has a market capitalization of $2.77 trillion. 
Buying $1000 In MSFT: If an investor had bought $1000 of MSFT stock 20 years ago, it would be worth $14,942.33 today based on a price of $372.10 for MSFT at the time of writing.
<h3>Microsoft's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743717637_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSFT

Here's How Much $1000 Invested In Microsoft 20 Years Ago Would Be Worth Today

13 analysts have shared their evaluations of Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Kroger, revealing an average target of $70.46, a high estimate of $75.00, and a low estimate of $61.00. This current average reflects an increase of 1.85% from the previous average price target of $69.18. 
<img src="https://www.benzinga.com/files/images/story/2025/1743717635_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Kroger by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Heinbockel</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$73.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$74.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$65.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Ken Goldman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$73.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$73.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$73.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>John Heinbockel</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$71.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Leah Jordan</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$61.00</td>
<td>-</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Ken Goldman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$69.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Kroger. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Kroger compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Kroger's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Kroger's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/KR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Kroger analyst ratings.</a>
<h2>Unveiling the Story Behind Kroger</h2>
Kroger is one of the largest grocery retailers in the United States with more than 2,700 stores across a portfolio of over 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The firm also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.
<h3>Kroger's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Kroger's revenue growth over a period of 3 months has faced challenges. As of 31 January, 2025, the company experienced a revenue decline of approximately -7.44%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 1.79%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Kroger's ROE stands out, surpassing industry averages. With an impressive ROE of 5.8%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Kroger's ROA stands out, surpassing industry averages. With an impressive ROA of 1.07%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Kroger's debt-to-equity ratio surpasses industry norms, standing at 3.03. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Expectations For Kroger's Future

In the current session, Revolve Gr Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) is trading at $19.36, after a 13.69% decrease. Over the past month, the stock fell by 17.86%, and in the past year, by 2.07%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1743717617_0.png" alt="Past Year Chart" />

<h3>Revolve Gr P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Revolve Gr has a better P/E ratio of 32.51 than the aggregate P/E ratio of 21.11 of the Specialty Retail industry. Ideally, one might believe that Revolve Gr Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743717617_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

RVLV

Price Over Earnings Overview: Revolve Gr

On April 3, 2025, Applovin Confirms It Has Provided Indication Of Interest To The US President To Explore Purchase Of TikTok In All Markets Outside Of China - Filing

GameStop Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares are trading higher in Thursday&#8217;s after-hours session after a regulatory filing showed CEO Ryan Cohen increased his <a href="https://www.benzinga.com/quote/GME/insider-trades">stake in the company</a>.
What To Know: In a new filing released after the market close on Thursday, Cohen disclosed the purchase of 500,000 shares of GameStop at an average price of $21.55 per share. The purchases were made in the open market on Thursday.
Cohen now owns a total of approximately 37.3 million shares of GameStop, representing an 8.4% stake in the video game retailer, purchased for a total of approximately $106.85 million. 
Cohen&#8217;s purchase comes after the company reported fourth-quarter financial results and announced the approval of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a <a href="https://www.benzinga.com/general/gaming/25/03/44482313/gamestop-q4-earnings-revenue-miss-eps-beat-shares-surge-as-board-approves-bitcoin-as-treasury-reserve-asset" target="_blank" rel="noreferrer noopener">treasury reserve asset</a> last week.
GameStop shares surged on the announcement, but gave back the gains the following day after the company announced plans to offer $1.3 billion of its convertible senior notes in a private offering, and use the proceeds to buy Bitcoin. 
GME Price Action: <a href="http://benzinga.com/quote/gme">GameStop shares</a> were up 3.41% after-hours, trading at $21.76 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Check This Out: • <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44609608/bitcoin-slips-12-in-3-months-despite-corporate-buying-whats-behind-the-decline-and-whats-next">Bitcoin Slips 12% In 3 Months Despite Corporate Buying – What&#8217;s Behind The Decline And What&#8217;s Next?</a>
Photo: Shutterstock.

Gaming

Insider Trades

After-Hours Center

Movers

$BTC

Ryan Cohen Buys GameStop Stock On Thursday: What Investors Need To Know

Mexican equities staged a historic rally on Thursday, defying a <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44618811/trump-tariffs-trigger-sell-off-on-holding-ast-spacemobile-lululemon-shopify-robinhood-tank">global market sell-off</a>. 
When President Donald Trump announced steep trade tariffs <a href="https://www.benzinga.com/topic/tariffs">targeting key U.S. partners</a>, he spared Mexico and Canada.
The United States-Mexico-Canada Agreement (USMCA)—a trade agreement that went into effect on July 1, 2020—shields U.S. neighbors from the immediate fallout.
The decision surprised market participants, who had expected a heavy tariff on the Central American economy. After all, Mexico runs a large trade surplus in goods with the U.S.
See Also: <a href="https://www.benzinga.com/government/regulations/25/04/44635144/fridays-jobs-report-could-be-make-or-break-moment-after-trumps-tariff-shock">Friday&#8217;s Jobs Report Could Be Make-Or-Break Moment After Trump&#8217;s Tariff Shock</a>
<h3 class="wp-block-heading">Mexican Equity ETF Outperforms S&amp;P 500 By Widest Margin Since September 1998</h3>
The iShares MSCI Mexico ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWW#NYSE">EWW</a>) — a popular vehicle for U.S. investors seeking exposure to Mexican equities — surged 4.5% on the day. This marks its strongest one-day gain since June 2024.
Its performance was aided by the Mexican peso, which rose 1.4% against the dollar. 
Meanwhile, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) plummeted 4.8%. That&#8217;s the worst daily performance since June 2020. 
This sets up an extraordinary 9.2 percentage point outperformance by Mexican stocks over their U.S. counterparts — a historically rare divergence.
According to historical market data, a performance gap of this magnitude between the two ETFs hasn't been seen since Sept. 15, 1998, when the Bank of Mexico intervened to defend the peso during a capital exodus from emerging markets triggered by Russia's default crisis.
Top daily performers included Operadora de Sites Mexicanos, S.A.B. de C.V. (OTCPK: OPMXF), which surged 5.5%, Bolsa Mexicana de Valores, S.A.B. de C.V. (OTCPK: BOMXF), up 4.7%, and Grupo Carso, S.A.B. de C.V. (OTCPK: GPOVF), which gained 3.9%.
<h3 class="wp-block-heading">Which Tariffs Are Applied To Mexico? </h3>
According to Goldman Sachs economist Alberto Ramos, the April 2 tariff order does not alter existing restrictions placed under the IEEPA (International Emergency Economic Powers Act) related to fentanyl and migration issues.
"USMCA-compliant goods will continue to see 0% tariff; non-USMCA compliant goods will face a 25% tariff, while non-compliant energy and potash exports are subject to a 10% levy," Ramos wrote in a note. 
Should the IEEPA orders be lifted, non-compliant goods would face a 12% "reciprocal" tariff, while USMCA-compliant exports would retain preferential access.
Mexico&#8217;s exports to the U.S. account for over 27% of GDP, underscoring the country's elevated sensitivity to U.S. trade policy. 
Ramos estimates that, under current rules, average U.S. tariffs on Mexican imports amount to roughly 8%, assuming most trade shifts to USMCA-compliant channels. 
Should more trade migrate to USMCA-compliant categories and if reciprocal tariffs replace IEEPA orders, the average effective tariff rate could fall slightly above 6%, improving Mexico's competitive positioning.
Despite the relief rally in Mexican assets, the economist cautions that Mexico remains indirectly exposed to global fallout. 
The broader package of reciprocal tariffs could dampen global growth and weigh on U.S. industrial demand, which would eventually affect Mexican exporters. 
&#8220;All in, in relative terms Mexico's external competitiveness was not hurt by today's announcements versus the current tariff baseline, but indirectly Mexico and LatAm could suffer from the potential impact on US and global growth of the broad reciprocal tariffs and any eventual retaliatory measures,&#8221; he said. 
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44635144/fridays-jobs-report-could-be-make-or-break-moment-after-trumps-tariff-shock">Friday&#8217;s Jobs Report Could Be Make-Or-Break Moment After Trump&#8217;s Tariff Shock</a></li>
</ul>
Image: Shutterstock

Analyst Color

Government

Large Cap

Latin America

Regulations

Broad U.S. Equity ETFs

Emerging Markets

Emerging Market ETFs

Econ #s

ETFs

BOMXF

GPOVF

GPOVY

OPMXF

Mexican Stocks Notch Widest 1-Day Rally Versus S&P 500 Since 1998 As Trump Spares Mexico From Tariffs

The price will be not less than $14.00 and not more than $17.00 per share. The tender offer will expire at 5:00 p.m., Eastern Time, on May 1, 2025, unless extended or withdrawn.&nbsp;

PAMT

PAMT Commences Modified Dutch Auction Tender Offer To Purchase Up To 435,000 Shares, Or About 2.0% Of Its Outstanding Common Stock

COOK

Traeger Launches The Flatrock 2 Zone Griddle

Guidance

Exxon Mobil Expects Change In Liquids Prices And Gas Prices To Each Add $0.0B - $0.4B To Q1 Upstream Earnings Vs. Q4 Earnings

<h3>Gainers</h3>
<ul>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) stock rose 8.1% to $0.69 during Thursday's after-market session. The market value of their outstanding shares is at $18.0 million. </li>
<li>Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares rose 7.55% to $5.27. The market value of their outstanding shares is at $868.7 million. </li>
<li>Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) shares moved upwards by 5.99% to $2.93. The company's market cap stands at $388.2 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) stock moved upwards by 5.5% to $0.75. The market value of their outstanding shares is at $7.4 million. </li>
<li>Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) stock moved upwards by 5.2% to $30.34. The company's market cap stands at $1.0 billion. </li>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares rose 5.01% to $0.2. The company's market cap stands at $2.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>QuinStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) shares fell 5.2% to $15.5 during Thursday's after-market session. The market value of their outstanding shares is at $875.2 million. </li>
<li>Pop Culture Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) shares fell 4.63% to $0.55. The company's market cap stands at $8.2 million. </li>
<li>WiMi Hologram Cloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) shares fell 4.22% to $0.44. The market value of their outstanding shares is at $43.2 million. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock decreased by 4.22% to $0.05. The market value of their outstanding shares is at $2.8 million. </li>
<li>Star Fashion Culture (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STFS#NASDAQ">STFS</a>) shares decreased by 4.09% to $0.94. The company's market cap stands at $11.4 million. </li>
<li>Global Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) stock declined by 3.67% to $1.05. The company's market cap stands at $2.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLMZ

CPOP

GITS

MITQ

QNST

SEAT

SPHR

STFS

TNMG

VMEO

WIMI

12 Communication Services Stocks Moving In Thursday's After-Market Session

The Q-Gold common shares to be issued to Alamos upon closing of the Transaction, or at a later date, are to be based on a 10-day volume weighted average trading price prior to the date of issuance. The Transaction is expected to close in the second quarter of 2025.
&nbsp;

Asset Sales

Alamos Gold Reveals Sale Of Quartz Mountain Gold Project For Total Consideration Of Up To $21M And 9.9% Equity In Q-Gold Resources

<h3>Gainers</h3>
<ul>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares increased by 94.6% to $0.9 during Thursday's after-market session. The company's market cap stands at $10.3 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares moved upwards by 85.35% to $0.81. The market value of their outstanding shares is at $3.8 million. </li>
<li>Sangamo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) shares rose 29.54% to $0.81. The market value of their outstanding shares is at $180.9 million. </li>
<li>Aldeyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALDX#NASDAQ">ALDX</a>) shares rose 15.19% to $1.63. The market value of their outstanding shares is at $97.0 million. </li>
<li>Ernexa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares moved upwards by 10.49% to $0.2. The company's market cap stands at $10.4 million. </li>
<li>Coya Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COYA#NASDAQ">COYA</a>) shares increased by 8.19% to $6.6. The company's market cap stands at $110.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NeuroOne Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) stock declined by 36.2% to $0.55 during Thursday's after-market session. The company's market cap stands at $16.9 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock fell 28.95% to $0.47. </li>
<li>Genprex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) shares declined by 15.16% to $0.37. The market value of their outstanding shares is at $3.1 million. </li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) stock fell 13.37% to $0.75. The market value of their outstanding shares is at $1.8 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock declined by 9.28% to $5.67. The company's market cap stands at $9.3 million. </li>
<li>Aditxt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) stock declined by 7.53% to $5.16. The company's market cap stands at $5.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADTX

ALDX

BBLG

COYA

ENTO

ERNA

GNPX

NMTC

PRTG

SGMO

VRPX

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>XCHG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) stock increased by 19.0% to $1.5 during Thursday's after-market session. The market value of their outstanding shares is at $89.1 million. </li>
<li>Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) shares increased by 14.61% to $1.49. The market value of their outstanding shares is at $24.2 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock rose 10.39% to $2.23. The market value of their outstanding shares is at $74.5 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) stock increased by 10.22% to $0.68. The market value of their outstanding shares is at $33.9 million. The company's, Q4 earnings came out yesterday. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock increased by 9.84% to $4.35. The company's market cap stands at $2.6 million. </li>
<li>Eshallgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHGO#NASDAQ">EHGO</a>) stock increased by 9.61% to $1.05. The company's market cap stands at $26.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Baiya International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIYA#NASDAQ">BIYA</a>) shares declined by 8.9% to $3.36 during Thursday's after-market session. The company's market cap stands at $42.0 million. </li>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares decreased by 7.44% to $0.31. The company's market cap stands at $9.2 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock decreased by 6.03% to $0.27. The market value of their outstanding shares is at $5.7 million. </li>
<li>Aeries Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AERT#NASDAQ">AERT</a>) stock fell 5.44% to $0.65. The market value of their outstanding shares is at $29.0 million. </li>
<li>SUNation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) stock fell 5.31% to $0.25. </li>
<li>ConnectM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) shares fell 4.83% to $0.83. The market value of their outstanding shares is at $24.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Advanced Environmental Recycling Technologies

AERT

AREB

BIYA

CLIR

CNTM

DXST

EHGO

NEOV

SUNE

VSTE

WLGS

12 Industrials Stocks Moving In Thursday's After-Market Session

Offerings

Press Releases

Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering

Stock Split

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval

Earnings

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Small Cap

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Contracts

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

CTOR

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Athira Pharma

Aytu BioPharma

Biofrontera

Cingulate

Cocrystal Pharma

China Pharma Holding

Citius Pharmaceuticals

Evoke Pharma

Gelteq

Hoth Therapeutics

Impact BioMedical

IGC Pharma

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Pulmatrix

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Talphera

Traws Pharma

TherapeuticsMD

D. Boral Capital

HC Wainwright & Co.

EF Hutton

Screenshot 2024-08-06 at 7.17.40 PM

Biotech

TENK

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

Screenshot 2024-07-29 at 8.39.42 PM

From fighting cancer to treating bloodstream infections, Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is busy trying to solve some of the world&#39;s ills. That&#39;s picking up steam with two of its lead products close to commercialization. 

Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products

Screenshot 2024-07-24 at 5.43.01 PM

Interview

This Pharma Company Is Preparing To Launch Its Lead Candidate

Screenshot 2024-04-17 at 5.34.28 PM

Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment

Comments

Citius Pharmaceuticals

뉴스

파트너 / 기고자

벤징가 글로벌